These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 36670050)
1. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial. Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050 [TBL] [Abstract][Full Text] [Related]
2. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ; JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683 [TBL] [Abstract][Full Text] [Related]
3. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM; JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682 [TBL] [Abstract][Full Text] [Related]
4. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials. Zhou Y; Sardana D; Kuroko S; Haszard JJ; de Block MI; Weng J; Jefferies C; Wheeler BJ Diabet Med; 2024 Mar; 41(3):e15280. PubMed ID: 38197238 [TBL] [Abstract][Full Text] [Related]
5. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials. Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743 [TBL] [Abstract][Full Text] [Related]
6. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes. Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211 [TBL] [Abstract][Full Text] [Related]
7. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607 [TBL] [Abstract][Full Text] [Related]
8. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566 [TBL] [Abstract][Full Text] [Related]
9. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study. Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056 [No Abstract] [Full Text] [Related]
10. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660 [TBL] [Abstract][Full Text] [Related]
11. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial. Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375 [TBL] [Abstract][Full Text] [Related]
12. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial. Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331 [TBL] [Abstract][Full Text] [Related]
13. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial. Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661 [TBL] [Abstract][Full Text] [Related]
14. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life. Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543 [TBL] [Abstract][Full Text] [Related]
15. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D). Brown RE; Chu L; Norman GJ; Abitbol A Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977 [TBL] [Abstract][Full Text] [Related]
16. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial. Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139 [No Abstract] [Full Text] [Related]
17. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494 [No Abstract] [Full Text] [Related]
18. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342 [TBL] [Abstract][Full Text] [Related]
19. Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial. Kim JY; Jin SM; Sim KH; Kim BY; Cho JH; Moon JS; Lim S; Kang ES; Park CY; Kim SG; Kim JH Diabetologia; 2024 Jul; 67(7):1223-1234. PubMed ID: 38639876 [TBL] [Abstract][Full Text] [Related]
20. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial. Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]